Tonix Pharmaceuticals Holding annual revenue
2022
2023
2024
2025
Tonix Pharmaceuticals Holding Revenue Growth & History (TNXP)
Tonix Pharmaceuticals Holding reported $13.1M in revenue for fiscal 2025, an increase of 29.85% from the previous fiscal year.
View full Tonix Pharmaceuticals Holding company overviewTonix Pharmaceuticals Holding annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.1M | $3.0M | +29.85% |
| 2024 | 2024-12-31 | $10.1M | $2.3M | +29.94% |
| 2023 | 2023-12-31 | $7.8M | $7.8M | — |
| 2022 | 2022-12-31 | $0 | — | — |
Tonix Pharmaceuticals Holding quarterly revenue
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $13.5M | $11.5M | +577.88% |
| Q1 2026 | 2026-03-31 | $6.9M | $4.4M | +183.16% |
| Q4 2025 | 2025-12-31 | $5.4M | $2.8M | +108.75% |
| Q3 2025 | 2025-09-30 | $3.3M | $468,000 | +16.58% |
| Q2 2025 | 2025-06-30 | $2.0M | −$210,000 | −9.51% |
| Q1 2025 | 2025-03-31 | $2.4M | −$53,000 | −2.14% |
| Q4 2024 | 2024-12-31 | $2.6M | — | — |
| Q3 2024 | 2024-09-30 | $2.8M | −$1.2M | −29.26% |
| Q2 2024 | 2024-06-30 | $2.2M | — | — |
| Q1 2024 | 2024-03-31 | $2.5M | — | — |
| Q3 2023 | 2023-09-30 | $4.0M | — | — |
Tonix Pharmaceuticals Holding revenue growth trends
Tonix Pharmaceuticals Holding's latest reported quarter, Q2 2026, generated $13.5M in revenue, an increase of 577.88% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Tonix Pharmaceuticals Holding source filings ↗